Trump unveils deal to expand coverage and lower costs on obesity drugs
Mihaela Măncilă
WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. The drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that have soared in popularity in recent years. But access to the drugs has been a consistent problem for patients because of their cost — around $500 a month for higher doses — and insurance coverage
astăzi
din zilele anterioare